Triptolide inhibits neutrophil extracellular trap formation
Haiyu Guan1, Lifen Xie1, Zhenzhen Ji1
1Department of Nephrology, Integrated Hospital of Traditional Chinese Medicine and Western Medicine, Southern Medical University, Guangzhou, China.
Annals of Translational Medicine
|November 4, 2021
Summary
Triptolide (PG490) inhibits neutrophil extracellular traps (NETs) formation in vitro. This effect is independent of cellular reactive oxygen species (ROS) levels, suggesting therapeutic potential for Tripterygium wilfordii Hook F in related diseases.
Area of Science:
- Immunology
- Pharmacology
Background:
- Triptolide (PG490), a triterpene dicyclic oxide, is known to induce apoptosis in RAW 264.7 cells by increasing reactive oxygen species (ROS) and nitric oxide (NO).
- Neutrophil extracellular traps (NETs) are crucial for anti-bacterial processes in the human body.
Purpose of the Study:
- To investigate the effect of triptolide (PG490) on the formation of neutrophil extracellular traps (NETs).
Main Methods:
- Peripheral blood neutrophils were isolated from healthy volunteers and incubated with PG490.
- NETs formation and intracellular ROS levels were measured using fluorescence microscopy and a multifunctional microplate reader.
- SYTOX Green staining was used to detect NETs, and fluorescence intensity was quantified.
Main Results:
- PG490 significantly inhibited NETs formation compared to the 12-myristate-13-acetate (PMA) control group, as indicated by decreased SYTOX Green fluorescence.
- While PMA stimulation increased intracellular ROS, PG490 did not significantly alter ROS levels in the presence of PMA.
- The observed inhibition of NETs by PG490 was not associated with changes in cellular ROS.
Conclusions:
- Triptolide (PG490) inhibits neutrophil extracellular trap (NET) production in vitro.
- This inhibition mechanism is independent of cellular reactive oxygen species (ROS) levels.
- PG490, derived from Tripterygium wilfordii Hook F, may have potential in suppressing diseases associated with NET formation.


